Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
Sponsor: Centre Oscar Lambret
Summary
The scope of the trial is to identify proteomic signatures correlated with tumor response to neo-adjuvant chemotherapy.
Official title: Analysis of the Proteomic Signature in Breast Cancer Correlated With Tumor Response in Patients Necessitating a Neo-adjuvant Chemotherapy
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2007-02-22
Completion Date
2012-01-16
Last Updated
2026-09-17
Healthy Volunteers
No
Conditions
Interventions
Blood sampling
Taken at different times : inclusion, at the cycle 4 and at the cycle 6 during the neoadjuvant chemotherapy
BIOPSY
Biopsy at the moment of inclusion, before neoadjuvant chemotherapy
SURGERY
Surgery after neoadjuvant chemotherapy
Locations (5)
Intercommunal Hospital
Annemasse, France
Centre Oscar Lambret
Lille, France
Hopital Saint Vincent
Lille, France
Centre Henri Becquerel
Rouen, France
Geroges PIANTA Hospital
Thonon-les-Bains, France